5th Joint Transnational Call for Proposals (2022)

Basic Information

With its fifth transnational call (non-cofunded by the EC), ERA PerMed aims to foster research in prevention in personalised medicine. The overarching goal of the call is the development of tailor-made strategies for prevention of disease and disease progression, at three different levels: i. preventive measures decreasing the rate of incidence (primary prevention), ii. early detection to increase the efficacy of a preventive therapy, even before symptoms are developed (secondary prevention), and iii. interventions preventing disease recurrence or improving patients’ care and quality of life (tertiary prevention). Research on prevention from over-treatment or overmedicalisation in primary, secondary and tertiary personalised preventive approaches is optional and could be part of research proposals, if applicable. The clinical relevance of the proposed PM approach needs to be convincingly demonstrated.

Network ERA PerMed
Website https://erapermed.isciii.es/joint-calls/joint-transnational-call-2022/
Aim of the joint call The overall objectives of the call are to: • Support translational research projects in the field of personalised medicine; • Encourage and enable interdisciplinary collaborations towards implementation of PM, in combining pre-clinical or clinical research with bio-informatics components as well as ELSA research or implementation research, including health economics; • Encourage collaboration between academia (research teams from universities, higher education institutions, public research institutions, research centres), clinical/public health research (research teams from hospital/ public health, healthcare settings and other healthcare organisations), private partners e.g. SMEs (small and medium-sized enterprises) as well as policy makers, regulatory/HTA agencies and patient organisations.
Type of joint call Two Stages - Call with pre-proposals and full proposals submissions
Events
Launch date 01/12/2021
Deadline Pre-Proposal 17/02/2022 Submitted proposal: 174
Deadline Full-Proposal 14/06/2022 Submitted proposal: 60
Evaluation End Date 07/09/2022 Successful proposal: 24 Proposals funded: 24
Is call co-funded? No
Call follow up funding
  • There are mechanisms in place to monitor
Call reasons
  • Achieving critical mass
  • Sharing competences and associated work
  • Addressing global issues
  • Access to expertise from different countries
  • Addressing specific scientific and technological issues
Research fields
  • Biotechnology
  • Health
  • Information and communication technologies
  • Socio-economics sciences and humanities
Type of research
  • Basic research
  • Applied Research
Target groups
  • Higher Education Institutions (HEIs)
  • Public Research Organisations (PROs)
  • Private and Semi-private Research and Technology Organisations (RTOs)
  • SME (Small and Medium Enterprises)
  • Other: Patient organisations
Participating networks n/a

Organisations Participating

Country Organisation
Austria Austrian Science Fund (FWF)
Belgium National Fund for Scientific Research (FNRS)
Brazil Brazilian National Council for the State Funding Agencies (CONFAP)
Canada Quebec Research Fund - Health (FRQS)
Chile National Research and Development Agency (ANID)
Croatia Ministry of Science, Education and Sports (MSES-MZOS)
Denmark Innovation Fund Denmark (Innofond)
Estonia Estonian Science Foundation (ETAG)
France National Research Agency (ANR)
Germany Federal Ministry of Education and Research (BMBF)
Germany Federal Ministry of Health (BMG)
Germany Saxon State Ministry for science, culture and tourism (SMWK)
Hungary National Research, Development and Innovation Office (NKFIH)
Ireland Health Research Board (HRB)
Israel Ministry of Health (CSO-MOH)
Italy Lombardy Foundation for Biomedical Research (FRRB)
Italy Ministry of Health (MOH/MDS)
Italy Tuscany Region (TOS)
Latvia State Education Development Agency (VIAA)
Lithuania Research Council of Lithuania (LSC/LMT/RCL)
Luxembourg National Fund for Research (FNR)
Norway Research Council of Norway (RCN)
Poland National Centre for Research and Development (NCBiR)
Romania Executive Agency for Higher Education, Research, Development and Innovation Funding (UEFISCDI)
Slovenia Ministry of Education, Science, Culture and Sport (MESCS/MIZS)
South Africa South African Medical Research Council (SAMRC)
Spain DEPARTMENT OF HEALTH - GOVERNMENT OF CATALONIA (DDS-GDC)
Spain Government of Navarra (CFN)
Spain Institute of Health Carlos III (ISCIII)
Spain Spanish Association Against Cancer Scientific Foundation (AECC FC)
Sweden Swedish Governmental Agency for Innovation Systems (VINNOVA)
Taiwan National Science and Technology Council / Ministry of Science and Technology (NSTC / MoST Taiwan)
Türkiye The Scientific and Technological Research Council of Turkey (TUBITAK)

Funded Projects

Acronym Title Start End No. partners
BIPCOM MEDICAL COMORBIDITIES IN BIPOLAR DISORDER: CLINICAL VALIDAT... 01/02/2023 31/01/2026 8
DAWN-AF Digital Twins to Treat Atrial Fibrillation 01/03/2023 28/02/2026 6
DEEPEN-iRBD Prodromal DEtErminants for PhENoconversion of idiopathic RBD... 01/02/2023 31/01/2026 8
ETAP Early diagnosis and personalized Therapy in Autism spectrum ... 5
Glioma-PerMed Glioma invasion assays as a predictive tool for personalized... 5
IPerGlio Improving personalised glioblastoma care by intertwined immu... 01/05/2023 30/04/2026 6
KidneySign An integrated multi-omics signature of kidney fibrosis for C... 02/05/2023 01/05/2026 6
LANTERN CANCER MULTI-OMICS AVATARS FOR INTEGRATED PRECISION MEDICINE 01/04/2023 31/03/2026 6
MG-PerMed Personalising myasthenia gravis medicine: from “one-fits-all... 01/03/2023 28/02/2026 6
ONAKI-ICI Towards a personalized clinical management of oncologic pati... 01/04/2023 31/03/2026 7
OPTIMA Omics Approach for Personalized Prevention of Type 2 Diabete... 01/05/2023 30/04/2026 4
OVA-PDM Personalizing the clinical decision making in ovarian cancer... 01/04/2023 31/03/2026 6
OmegaPerMed Optimizing omega-3 supplementation to resolve inflammation i... 01/01/2023 31/12/2025 5
PARADISE PersonAlisation of RelApse risk in autoimmune DISEase 03/04/2023 02/04/2026 8
PERMANENS Towards Personalised Clinical Management of Suicide Risk thr... 01/03/2023 28/02/2026 5
PERMEPSY Towards a personalized medicine approach to psychological tr... 01/05/2023 30/04/2026 6
PORTRAIT A multi-omic stratification and a non invasive tool for earl... 7
RELIABLE Targeting subclinical motor and cognitive impairment in pati... 01/03/2023 28/02/2026 4
SIGNAL Body fluid proteome SIGnatures for persoNALised intervention... 01/05/2023 30/04/2026 6
SPAREKID MULTI-MARKERS RISK ASSESSMENT OF KIDNEY SENSITIVITY TO INJUR... 20/03/2023 19/03/2026 6
Stracyfic Patient Stratification by Standardization of the Image-based... 01/06/2023 31/05/2026 5
UBIOBCA Urine biomarkers for bladder cancer initial detection and su... 01/05/2023 30/04/2026 5
UriCoV Urinary peptidomic patterns of Long-COVID syndrome 01/03/2023 7
miRPOC miRNA as biomarkers in early detection and personalized trea... 4